Publications by authors named "Shellie M Callahan"

Claim this Profile
I
Integrin Receptors Play a Key Role in the Regulation of Hepatic CYP3A.
Kristina Jonsson-Schmunk, Piynauch Wonganan, Jin Huk Choi, Shellie M Callahan, Maria A Croyle

Drug Metab Dispos· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.
Piyanuch Wonganan, Kristina Jonsson-Schmunk, Shellie M Callahan, Jin Huk Choi, Maria A Croyle

Drug Metab Dispos· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and macromolecular alterations of recombinant adenoviral vectors do not resolve changes in hepatic drug metabolism during infection.
Shellie M Callahan, Piyanuch Wonganan, Maria A Croyle

Virol J· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlled inactivation of recombinant viruses with vitamin B2.
Shellie M Callahan, Piyanuch Wonganan, Linda J Obenauer-Kutner, Suganto Sutjipto, Joseph D Dekker

J Virol Methods· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal pathophysiology after systemic administration of recombinant adenovirus: changes in renal cytochromes P450 based on vector dose.
Hong T Le, Michael P Boquet, Erin A Clark, Shellie M Callahan, Maria A Croyle

Hum Gene Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of transgene expression on drug metabolism following systemic adenoviral vector administration.
Shellie M Callahan, Michael P Boquet, Xin Ming, Lane J Brunner, Maria A Croyle

J Gene Med· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considerations for use of recombinant adenoviral vectors: dose effect on hepatic cytochromes P450.
Shellie M Callahan, Xin Ming, Shirley K Lu, Lane J Brunner, Maria A Croyle

J Pharmacol Exp Ther· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.
Shirley K Lu, Shellie M Callahan, Runyan Jin, Lane J Brunner

Eur J Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of high-density lipoprotein associated cyclosporine on hepatic metabolism and renal function.
Taekrho Kim, Shellie M Callahan, Kishor M Wasan, Lane J Brunner

PDA J Pharm Sci Technol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum.
Maria A Croyle, Shellie M Callahan, Alberto Auricchio, Gregg Schumer, Klause D Linse

J Virol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sodium alterations on hepatic cytochrome P450 3A2 and 2C11 and renal function in rats.
Jinrong Liu, Shellie M Callahan, Lane J Brunner

Drug Dev Ind Pharm· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of hepatic CYP3A1/2 and CYP2C11 by cyclosporine is not mediated by altering growth hormone levels.
Shirley K Lu, Shellie M Callahan, Lane J Brunner

J Pharmacol Exp Ther· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis